Your browser doesn't support javascript.
loading
Trajectory of viral load in a prospective population-based cohort with incident SARS-CoV-2 G614 infection
Helen C Stankiewicz Karita; Tracy Q Dong; Christine Johnston; Kathleen M Neuzil; Michael K Paasche-Orlow; Patricia J Kissinger; Anna Bershteyn; Lorna Thorpe; Meagan Deming; Angelica Kottkamp; Miriam Laufer; Raphael Landovitz; Alfred Luk; Risa Hoffman; Pavitra Roychoudhury; Craig Magaret; Alex Greninger; Meeili Huang; Keith Jerome; Mark Wener; Connie L Celum; Helen Y Chu; Jared Baeten; Anna Wald; Ruanne V Barnabas; Elizabeth R Brown.
Afiliação
  • Helen C Stankiewicz Karita; University of Washington
  • Tracy Q Dong; Fred Hutchinson Cancer Research Center
  • Christine Johnston; University of Washington
  • Kathleen M Neuzil; University of Maryland
  • Michael K Paasche-Orlow; Boston University School of Medicine
  • Patricia J Kissinger; Tulane University
  • Anna Bershteyn; New York University Grossman School of Medicine
  • Lorna Thorpe; New York University Grossman School of Medicine
  • Meagan Deming; University of Maryland
  • Angelica Kottkamp; New York University Grossman School of Medicine
  • Miriam Laufer; University of Maryland
  • Raphael Landovitz; University of California Los Angeles
  • Alfred Luk; Tulane University
  • Risa Hoffman; University of California Los Angeles
  • Pavitra Roychoudhury; University of Washington
  • Craig Magaret; University of Washington
  • Alex Greninger; University of Washington
  • Meeili Huang; University of Washington
  • Keith Jerome; University of Washington
  • Mark Wener; University of Washington
  • Connie L Celum; University of Washington
  • Helen Y Chu; University of Washington
  • Jared Baeten; University of Washington
  • Anna Wald; University of Washington
  • Ruanne V Barnabas; University of Washington
  • Elizabeth R Brown; Fred Hutchinson Cancer Research Center
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21262754
ABSTRACT
ImportanceSARS-CoV-2 viral trajectory has not been well-characterized in documented incident infections. These data will inform SARS-CoV-2 natural history, transmission dynamics, prevention practices, and therapeutic development. ObjectiveTo prospectively characterize early SARS-CoV-2 viral shedding in persons with incident infection. DesignProspective cohort study. SettingSecondary data analysis from a multicenter study in the U.S. ParticipantsThe samples derived from a randomized controlled trial of 829 community-based asymptomatic participants recently exposed (<96 hours) to persons with SARS-CoV-2. Participants collected daily mid-turbinate swabs for SARS-CoV-2 detection by polymerase-chain-reaction and symptom diaries for 14-days. Persons with negative swab for SARS-CoV-2 at baseline who developed infection during the study were included in the analysis. ExposureLaboratory-confirmed SARS-CoV-2 infection. Main outcomes and measuresThe observed SARS-CoV-2 viral shedding characteristics were summarized and shedding trajectories were examined using a piece-wise linear mixed-effects modeling. Whole viral genome sequencing was performed on samples with cycle threshold (Ct)<34. ResultsNinety-seven persons (57% women, median age 37-years) developed incident infections during 14-days of follow-up. Two-hundred fifteen sequenced samples were assigned to 15 lineages that belonged to the G614 variant. Forty-two (43%), 18(19%), and 31(32%) participants had viral shedding for 1 day, 2-6 days, and [≥]7 days, with median peak viral load Ct of 38.5, 36.7, and 18.3, respectively. Six (6%) participants had 1-6 days of observed viral shedding with censored duration. The peak average viral load was observed on day 3 of viral shedding. The average Ct value was lower, indicating higher viral load, in persons reporting COVID-19 symptoms than asymptomatic. Using the statistical model, the median time from shedding onset to peak viral load was 1.4 days followed by a median of 9.7 days before clearance. Conclusions and RelevanceIncident SARS-CoV-2 G614 infection resulted in a rapid viral load peak followed by slower decay and positive correlation between peak viral load and shedding duration; duration of shedding was heterogeneous. This longitudinal evaluation of the SARS-CoV-2 G614 variant with frequent molecular testing may serve as a reference for comparing emergent viral lineages to inform clinical trial designs and public health strategies to contain the spread of the virus. KEY POINTSO_ST_ABSQuestionC_ST_ABSWhat are the early SARS-CoV-2 G614 viral shedding characteristics in persons with incident infection? FindingsIn this prospective cohort of 97 community-based participants who collected daily mid-turbinate swabs for SARS-CoV-2 detection after recent exposure to SARS-CoV-2, viral trajectory was characterized by a rapid peak followed by slower decay. Peak viral load correlated positively with symptoms. The duration of shedding was heterogeneous. MeaningA detailed description of the SARS-CoV-2 G614 viral shedding trajectory serves as baseline for comparison to new viral variants of concern and inform models for the planning of clinical trials and transmission dynamics to end this pandemic.
Licença
cc_by_nc_nd
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Cohort_studies / Experimental_studies / Estudo observacional / Estudo prognóstico / Rct Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
...